Trinity Biotech plc
TRIB · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $61,555 | $56,832 | $62,521 | $81,149 |
| % Growth | 8.3% | -9.1% | -23% | – |
| Cost of Goods Sold | $40,114 | $37,382 | $52,731 | $54,888 |
| Gross Profit | $21,441 | $19,450 | $22,048 | $33,454 |
| % Margin | 34.8% | 34.2% | 35.3% | 41.2% |
| R&D Expenses | $4,543 | $4,379 | $4,138 | $4,497 |
| G&A Expenses | $0 | $0 | $0 | $24,683 |
| SG&A Expenses | $28,815 | $31,152 | $29,166 | $24,683 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $9,248 | $10,964 | -$343 | $336 |
| Operating Expenses | $42,606 | $46,495 | $32,961 | $29,516 |
| Operating Income | -$21,165 | -$27,045 | -$15,269 | $3,938 |
| % Margin | -34.4% | -47.6% | -24.4% | 4.9% |
| Other Income/Exp. Net | -$9,565 | -$9,882 | -$24,431 | -$5,862 |
| Pre-Tax Income | -$30,730 | -$36,927 | -$43,780 | -$1,924 |
| Tax Expense | $486 | -$59 | -$194 | -$74 |
| Net Income | -$31,789 | -$24,018 | -$41,002 | $875 |
| % Margin | -51.6% | -42.3% | -65.6% | 1.1% |
| EPS | -1.77 | -3.2 | -6 | 0.21 |
| % Growth | 44.7% | 46.7% | -2,957.1% | – |
| EPS Diluted | -1.77 | -3.2 | -5.2 | 0.16 |
| Weighted Avg Shares Out | 17,960 | 7,655 | 6,747 | 4,180 |
| Weighted Avg Shares Out Dil | 17,960 | 7,655 | 7,775 | 5,326 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $1,171 | $303 | $1,223 |
| Interest Expense | $9,565 | $10,148 | $24,734 | $7,097 |
| Depreciation & Amortization | $1,865 | $1,776 | $2,333 | $2,744 |
| EBITDA | -$16,905 | -$24,098 | -$16,713 | $10,592 |
| % Margin | -27.5% | -42.4% | -26.7% | 13.1% |